LMAT director granted dividend equivalent rights

LEMAITRE VASCULAR INC President and Director David B. Roberts reported routine compensation-related transactions involving dividend equivalent rights on June 4, 2026.

Rhea-AI Filing Summary

LEMAITRE VASCULAR INC President and Director David B. Roberts reported routine compensation-related transactions involving dividend equivalent rights on June 4, 2026. These are derivative awards that mirror dividends on previously granted stock-based awards rather than open-market trades.

The filing shows nine acquisitions coded as grants, each adding small fractional dividend equivalent rights tied to restricted stock unit and performance share unit awards granted on December 12, 2022, December 8, 2023, December 6, 2024, February 18, 2025, and December 10, 2025. Each dividend equivalent right is the economic equivalent of one share of common stock and vests proportionately with its underlying award. No shares were bought or sold in the market.

Insider Trade Summary

Grant/Award: 21.3718 shares

Grant/Award 9 txns

Insider Roberts David B

Role President and Director

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights	1.8244	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	1.8244	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	3.1166	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	3.7342	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	2.7084	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	3.0684	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	0.2622	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	0.2965	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	4.5367	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 141.9696 contracts (Direct)

Footnotes (9)

1. F1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
2. F2. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
3. F3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
4. F4. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
5. F5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
6. F6. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
7. F7. These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
8. F8. These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
9. F9. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Key Figures

Transactions acquiring rights: 9 derivative transactions Largest single grant: 4.5367 rights Example post-transaction holding: 28.0291 rights +2 more

5 metrics

Transactions acquiring rights 9 derivative transactions Dividend equivalent rights grants on June 4, 2026

Largest single grant 4.5367 rights Dividend equivalent rights tied to common stock on June 4, 2026

Example post-transaction holding 28.0291 rights Total dividend equivalent rights in one line after a June 4, 2026 grant

Another post-transaction holding 23.3420 rights Dividend equivalent rights balance in a separate line after June 4, 2026 grant

Smallest single grant 0.2622 rights Dividend equivalent rights acquisition on June 4, 2026

Key Terms

Dividend Equivalent Rights, restricted stock unit award, performance share unit award, economic equivalent of one share

4 terms

Dividend Equivalent Rights financial

"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock unit award financial

"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023"

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

performance share unit award financial

"These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025"

economic equivalent of one share financial

"Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LEMAITRE VASCULAR (LMAT) report for David B. Roberts?

David B. Roberts reported grants of dividend equivalent rights, not stock sales or purchases. On June 4, 2026, he received nine small compensation-related awards that mirror dividends on existing restricted stock unit and performance share unit grants, each economically equivalent to one share of LMAT common stock.

Were any LEMAITRE VASCULAR (LMAT) shares bought or sold in this Form 4?

No LMAT common shares were bought or sold in this Form 4. All nine transactions are coded as acquisitions of dividend equivalent rights, which track dividends on prior equity awards and vest with those awards, rather than representing open-market trades in the stock.

What are dividend equivalent rights in the LEMAITRE VASCULAR (LMAT) Form 4?

Dividend equivalent rights give the holder value equal to dividends on underlying awards. For LMAT, each right is the economic equivalent of one common share, accruing on restricted stock units and performance share units and vesting proportionately with those original equity awards.

Which prior equity awards generated the LMAT dividend equivalent rights for David B. Roberts?

The dividend equivalent rights accrue on several earlier LMAT equity grants. They relate to restricted stock unit and performance share unit awards granted on December 12, 2022, December 8, 2023, December 6, 2024, February 18, 2025, and December 10, 2025, and vest alongside those grants.

How many dividend equivalent right transactions did LEMAITRE VASCULAR (LMAT) disclose?

LMAT disclosed nine separate dividend equivalent right transactions for David B. Roberts. The Form 4 transaction summary shows nine acquisition entries, all derivative-type awards with no corresponding sales, gifts, tax withholdings, or restructurings reported in this filing.

Do the LMAT dividend equivalent rights vest immediately for David B. Roberts?

No, the dividend equivalent rights vest proportionately with the underlying awards. For each referenced restricted stock unit and performance share unit grant, the related dividend equivalent rights follow the same vesting schedule, aligning their value with the long-term incentive structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 05:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roberts David B

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR, INC.

63 SECOND AVENUE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and Director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	06/04/2026		A		1.8244		(1)	(1)	Common Stock	1.8244	$0	23.342	D
Dividend Equivalent Rights	(2)	06/04/2026		A		1.8244		(2)	(2)	Common Stock	1.8244	$0	22.659	D
Dividend Equivalent Rights	(3)	06/04/2026		A		3.1166		(3)	(3)	Common Stock	3.1166	$0	26.7078	D
Dividend Equivalent Rights	(4)	06/04/2026		A		3.7342		(4)	(4)	Common Stock	3.7342	$0	28.0291	D
Dividend Equivalent Rights	(5)	06/04/2026		A		2.7084		(5)	(5)	Common Stock	2.7084	$0	14.3837	D
Dividend Equivalent Rights	(6)	06/04/2026		A		3.0684		(6)	(6)	Common Stock	3.0684	$0	15.0482	D
Dividend Equivalent Rights	(7)	06/04/2026		A		0.2622		(7)	(7)	Common Stock	0.2622	$0	1.6805	D
Dividend Equivalent Rights	(8)	06/04/2026		A		0.2965		(8)	(8)	Common Stock	0.2965	$0	1.744	D
Dividend Equivalent Rights	(9)	06/04/2026		A		4.5367		(9)	(9)	Common Stock	4.5367	$0	8.3753	D

Explanation of Responses:

1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

2. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

4. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

6. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

7. These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

8. These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

9. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Laurie A. Churchill, Attorney-in-fact	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)